Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.9M Sell
57,752
-300
-0.5% -$103K 6.72% 2
2026
Q1
$20.4M Buy
58,052
+603
+1% +$215K 7.03% 2
2025
Q4
$18.8M Sell
57,449
-712
-1% -$226K 6.41% 2
2025
Q3
$16.4M Sell
58,161
-2,619
-4% -$760K 5.61% 3
2025
Q2
$17M Buy
60,780
+348
+0.6% +$98.6K 6.08% 2
2025
Q1
$18.8M Sell
60,432
-3
-0% -$886 6.9% 2
2024
Q4
$15.8M Buy
60,435
+577
+1% +$171K 5.83% 2
2024
Q3
$19.3M Sell
59,858
-3,607
-6% -$1.18M 6.83% 2
2024
Q2
$19.8M Sell
63,465
-72
-0.1% -$21.2K 7.26% 2
2024
Q1
$18.1M Sell
63,537
-162
-0.3% -$47.4K 6.76% 2
2023
Q4
$18.3M Buy
63,699
+216
+0.3% +$58.9K 7.3% 2
2023
Q3
$17.1M Sell
63,483
-11
-0% -$2.75K 7.32% 2
2023
Q2
$14.1M Buy
63,494
+523
+0.8% +$121K 5.84% 2
2023
Q1
$15.2M Buy
62,971
+572
+0.9% +$140K 6.56% 2
2022
Q4
$16.4M Sell
62,399
-1,477
-2% -$396K 7.36% 2
2022
Q3
$14.4M Buy
+63,876
New +$15.5M 6.98% 2
2022
Q2
Sell
-63,890
Closed -$15.4M 75
2022
Q1
$15.4M Sell
63,890
-663
-1% -$152K 6.11% 2
2021
Q4
$14.5M Sell
64,553
-55
-0.1% -$11.6K 5.55% 2
2021
Q3
$13.1M Buy
64,608
+3,320
+5% +$764K 5.46% 2
2021
Q2
$14.9M Buy
61,288
+1,576
+3% +$388K 6.28% 2
2021
Q1
$14.9M Buy
59,712
+183
+0.3% +$43.7K 8.01% 2
2020
Q4
$13.7M Buy
59,529
+290
+0.5% +$66.9K 6.67% 2
2020
Q3
$13.5M Sell
59,239
-1,577
-3% -$391K 7.14% 2
2020
Q2
$14.3M Sell
60,816
-584
-1% -$133K 8.5% 2
2020
Q1
$12.4M Sell
61,400
-854
-1% -$187K 9.05% 1
2019
Q4
$15M Sell
62,254
-1,621
-3% -$357K 8.35% 2
2019
Q3
$12.4M Sell
63,875
-1,088
-2% -$209K 7.45% 1
2019
Q2
$11.4M Buy
64,963
+2,030
+3% +$363K 7.09% 1
2019
Q1
$12M Buy
62,933
+8,449
+16% +$1.61M 7.92% 1
2018
Q4
$10.6M Buy
54,484
+3,897
+8% +$760K 7.85% 1
2018
Q3
$10.5M Buy
50,587
+1,911
+4% +$377K 6.36% 3
2018
Q2
$8.98M Buy
48,676
+7,142
+17% +$1.26M 6.13% 3
2018
Q1
$7.08M Sell
41,534
-161
-0.4% -$29.6K 5.47% 2
2017
Q4
$7.25M Buy
+41,695
New +$7.38M 5.52% 2

Other funds holding AMGN

Oak Asset Management's AMGN Position: Q2 2026 in Review

Oak Asset Management reduced its Amgen (AMGN) stake by 0.52% in Q2 2026, selling an estimated $103K and leaving 57,752 shares worth $20.9M. The position accounts for 6.72% of the portfolio, ranked #2.

Oak Asset Management first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. 668 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Oak Asset Management held 57,752 shares of Amgen worth $20.9M as of Q2 2026.
  • Oak Asset Management sold 300 Amgen shares in Q2 2026, an estimated $103K.
  • Amgen made up 6.72% of Oak Asset Management's portfolio in Q2 2026, its #2 holding.
  • Oak Asset Management first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
  • 668 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Oak Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.